Myeloid differentiation of human cord blood CD34+ cells during ex vivo expansion using thrombopoietin, flt3-ligand and/or granulocyte-colony stimulating factor

Eun Seon Yoo, Kyung Ha Ryu, Hae Young Park, Chu Myung Seong, Wha Soon Chung, Seung Cheol Kim, Yong Mook Choi, Myong Joon Hahn, So Youn Woo, Ju Young Seoh

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

We investigated the phenotypic changes of human umbilical cord blood (CB) CD34+ cells during ex vivo expansion using thrombopoietin (TPO), flt3- ligand (FL), and/or granulocyte-colony stimulating factor (G-CSF). During ex vivo expansion of CD34+ cells isolated from human CB for up to 5 weeks, surface expression of molecules on the cultured cells including CD64 (FcγRI), CD32 (FcγRII). CD16 (FcγRIII), CD11b (MAC-1) and CD18 (β2- integrin) was analysed by flow cytometry along with simultaneous measurement of apoptosis by 7-aminoactinomycin D staining method. CD64, CD32 and/or CD18 expressing cells appeared in the cultures both with and without the addition of G-CSF until file tenth day. However, without G-CSF, CD16+ fractions did not appear and CD11b+ fractions were not maintained. With G-CSF, the CD16+ or CD11b+ fractions appeared only from the second week. These results suggest that G-CSF is necessary for the late stage of myeloid maturation during which CD16 and CD11b are expressed.

Original languageEnglish
Pages (from-to)1034-1040
Number of pages7
JournalBritish Journal of Haematology
Volume105
Issue number4
DOIs
StatePublished - 1999

Keywords

  • CD11b
  • CD16
  • CD34
  • Cord blood
  • Ex vivo expansion

Fingerprint

Dive into the research topics of 'Myeloid differentiation of human cord blood CD34+ cells during ex vivo expansion using thrombopoietin, flt3-ligand and/or granulocyte-colony stimulating factor'. Together they form a unique fingerprint.

Cite this